Actionable news
0
All posts from Actionable news
Actionable news in MRTX: Mirati Therapeutics, Inc.,

Mirati Therapeutics Inc.

Average Recommendation: Buy Average Target Price: 34.00
Number of Ratings: 7 Current Quarters Estimate: -0.99
FY Report Date: 12 / 2016 Current Year's Estimate: -4.10
Last Quarter's Earnings: -0.96 Median PE on CY...

More